626

· Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for 626, covering 2024-12-10 to 2025-11-26. Get the full timeline:

Most recent: Clinical Trial Update: The Purpose of This Study is to Evaluate the Efficacy and Safety of 626 in the Treatment of SLE [Phase 1, Phase 2]

See pricing